CLASS III ONGOING Drug recall · Reported 9 Oct 2024 · FDA Enforcement Report

Ciclopirox Gel 77%, For Dermatologic Use Only, Not for Use in Eyes recalled

Glenmark Pharmaceuticals Inc., U is recalling Ciclopirox Gel 77%, For Dermatologic Use Only, Not for Use in Eyes, distributed nationwide in the US. The recall was initiated on 30 Sep 2024 and the FDA has classified it as Class III.

Check your package

Lot, batch or date codesLot #s: a) 19242028, Exp. 04/30/2026; b) 19242028, Exp. 04/30/2026; c) 19242028, Exp. 04/30/2026
Quantity recalled11,568 tubes

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0002-2025
FDA event ID
95444
Recalling firm
Glenmark Pharmaceuticals Inc., U, Mahwah, NJ
Classification
Class III
Status
Ongoing
Recall initiated
30 Sep 2024
FDA classified
2 Oct 2024
Reported
9 Oct 2024
Type
Voluntary: Firm initiated
Customers notified by
N/A
Reason category
Packaging Defects

Timeline

30 Sep 2024Recall initiated by company
2 Oct 2024Classified by FDA+2 days
9 Oct 2024Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Defective Container: Firm received complaints of broken tube at the seal.

Packaging recalls include wrong labels, wrong products in the wrong bottle, missing leaflets, short-filled or empty capsules and seals that fail.

Product as listed by the FDA

Ciclopirox Gel 0.77%, For Dermatologic Use Only, Not for Use in Eyes, Rx Only, a) 30 gm Tube, NDC 68462-0455-35; b) 45 gm Tube, NDC 68462-0455-47; c) 100 gm Tube, NDC 68462-0455-94, Manufactured by: Glenmark Pharmaceuticals, Ltd., Colvale-Bardez, Goa 403513, India, Manufactured for: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 07430.

Where it was distributed

Nationwide in the US.

Nationwide

Questions about this recall

Is Ciclopirox Gel 77%, For Dermatologic Use Only, Not for Use in Eyes recalled?

Yes. Glenmark Pharmaceuticals Inc., U recalled Ciclopirox Gel 77%, For Dermatologic Use Only, Not for Use in Eyes on 30 Sep 2024. The recall is Class III and its status is Ongoing. Recall number D-0002-2025.

Why was it recalled?

Defective Container: Firm received complaints of broken tube at the seal.

Which lots are affected?

Lot #s: a) 19242028, Exp. 04/30/2026; b) 19242028, Exp. 04/30/2026; c) 19242028, Exp. 04/30/2026

Where was it sold?

Nationwide in the US.

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class III mean?

Class III recalls are for products unlikely to cause any adverse health consequence, usually labelling or quality issues.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Glenmark Pharmaceuticals Inc., U

All 141

Other Ciclopirox recalls

All 3
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIICiclopirox shampoo recalled by Perrigo New YorkCiclopiroxPerrigo New YorkPotency & AssayNationwide
DrugCLASS IIICiclopirox Shampoo recalled by Taro Pharmaceuticals U.S.ACiclopiroxTaro Pharmaceuticals U.S.APotency & AssayNationwide